News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CARBOGEN AMCIS Appoints Villemagne as VP Commercial


10/4/2011 10:30:49 AM

BUBENDORF, Switzerland (October 4th, 2011) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today the appointment of Pascal Villemagne as vice president commercial. In his new role, Villemagne will lead the company’s overall sales and marketing operations. He will report directly to Mark Griffiths, chief executive officer, and will serve on the company’s executive management team.

“CARBOGEN AMCIS provides a continuum of services, from bench to commercial-scale manufacturing. Pascal Villemagne’s commercialization and strategic development experience in the contract research and manufacturing arena will be an important asset to our organization,” says Mark Griffiths, CEO of CARBOGEN AMCIS. “I am very happy to welcome Pascal to CARBOGEN AMCIS’ management team.”

Pascal Villemagne brings 15 years of experience in the life science industry, amassed while serving in a variety of commercial leadership roles. Most recently, Villemagne served as vice president, contract manufacturing, at Farmhispania, an API contract manufacturing company based in Spain. Previous roles include sales and business development manager at Inabata and at Cambrex, as well as buyer of raw materials at Sanofi-Aventis.

"I am thrilled to join the leadership team of a leading provider of drug development and commercialization services such as CARBOGEN AMCIS,” said Villemagne. “I look forward to expanding the company’s regional sales and marketing strategies and to helping clients make critical decisions in drug development and commercialization more efficiently."

Villemagne earned a master of chemistry degree from the University of Lyon, France, and an advanced degree in purchasing from the Saint-Etienne School of Management in Lyon, France.

CARBOGEN AMCIS AG is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development, allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.

Dishman Group (www.dishmangroup.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and commercial API manufacturing services. Dishman Group improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe, China and India.

Jessica Hartman

Standing Partnership

540 Maryville Centre Drive, Suite 100

St. Louis, Missouri 63141

314.469.3500 office

314.469.3512 fax

Web site: www.standingpr.com

Blog: www.standingpr.com/blog


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES